A pilot study shows promise for a new treatment option for individuals with memory impairments caused by multiple sclerosis (MS).
Menu
The past five years have been arduous for the UK’s clinical trial landscape but what changes can be made to improve its viability for research.
Share this article According to GlobalData’s company profile on Viatris, Cancer treatment biomarkers was a key innovation area identified from patents. Viatris‘s grant share as